Pulsenmore Ltd. (PLSM)
$2.79-5.10%Close
SELL
Key stats
Short interest · FINRA settlement 2026-08-14
- Market cap
- $18M
- Avg volume
- 1.4M
- Beta
- 0.38
- P/E (TTM)
- -1.69
- Short % float
- 0.23%
- Days to cover
- 1.0
- SI change
- -46.4%
- 1W
- -3.46%
- 1M
- -18.66%
- 3M
- -37.86%
- YTD
- -62.09%
- vs SPY 1W
- -2.27%
- vs SPY 1M
- -21.98%
- vs SPY 3M
- -40.25%
- vs SPY YTD
- -73.85%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ICCCSELLImmuCell CorporationBEARQ 16$9.84-2.19%
- SNGXBUYSoligenix, Inc.RECOVERYQ -4$0.40+0.00%
- NCELSELLNewcelX Ltd.RECOVERYQ -19$3.46+6.13%
- TVRDSELLTvardi Therapeutics, Inc.CRISISQ -9$1.78-4.30%
- ABVCSELLABVC BioPharma, Inc.CRISISQ -6$0.84-5.62%
- CLRBBUYCellectar Biosciences, Inc.RECOVERYQ -17$2.52-2.70%
- CNTXBUYContext Therapeutics Inc.CRISISQ -15$0.47-6.00%
- SRPTBUYSarepta Therapeutics, Inc.RECOVERYQ 13$18.13-3.51%
- CGEMBUYCullinan Therapeutics, Inc.BULLQ 6$21.82+0.65%
- APGEBUYApogee Therapeutics, Inc.BULLQ 60$134.79+0.03%
- ATTOFLATAttovia Therapeutics, Inc.Q 18$20.62-0.87%
- EIKNBUYEikon Therapeutics, Inc. Common StockQ -15$11.16-2.02%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 12
- GROWTH
- 47
- GARP
- 7
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-24.5%
REV YoY-
ROE-40.8%
EPS YoY-
ROA-31.5%
GROSS81
OP-62
NET-75
[VALUATION]
P/E TTM-1.69
P/E FWD-
SECTOR PE22.57
INDUSTRY PE24.39
P/B0.65
P/FCF-
EV/EBITDA-1.42
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.88
ALTMAN Z-
CURR RATIO7.88
ND/EBITDA-
BETA0.38
